A citation-based method for searching scientific literature

Nancy Hamel, Bing-Jian Feng, Lenka Foretova, Dominique Stoppa-Lyonnet, Steven A Narod, Evgeny Imyanitov, Olga Sinilnikova, Laima Tihomirova, Jan Lubinski, Jacek Gronwald, Bohdan Gorski, Thomas v O Hansen, Finn C Nielsen, Mads Thomassen, Drakoulis Yannoukakos, Irene Konstantopoulou, Vladimir Zajac, Sona Ciernikova, Fergus J Couch, Celia M T Greenwood, David E Goldgar, William D Foulkes. Eur J Hum Genet 2011
Times Cited: 73







List of co-cited articles
672 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
20

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
20

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.
Yael Laitman, Bing-Jian Feng, Itay M Zamir, Jeffrey N Weitzel, Paul Duncan, Danielle Port, Eswary Thirthagiri, Soo-Hwang Teo, Gareth Evans, Ayse Latif,[...]. Eur J Hum Genet 2013
35
42

Founder mutations in BRCA1 and BRCA2 genes.
R Ferla, V Calò, S Cascio, G Rinaldi, G Badalamenti, I Carreca, E Surmacz, G Colucci, V Bazan, A Russo. Ann Oncol 2007
160
19

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
B Górski, T Byrski, T Huzarski, A Jakubowska, J Menkiszak, J Gronwald, A Pluzańska, M Bebenek, L Fischer-Maliszewska, E Grzybowska,[...]. Am J Hum Genet 2000
207
15

Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil.
Magda C B Gomes, Mauricio M Costa, Radovan Borojevic, Alvaro N A Monteiro, Roberto Vieira, Sergio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang,[...]. Breast Cancer Res Treat 2007
57
19

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
15

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
13

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
James D Fackenthal, Olufunmilayo I Olopade. Nat Rev Cancer 2007
309
13

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
131
13

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Diana Torres, Muhammad Usman Rashid, Fabian Gil, Angela Umana, Giancarlo Ramelli, Jose Fernando Robledo, Mauricio Tawil, Lilian Torregrosa, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2007
73
13

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
13

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
S L Neuhausen, A K Godwin, R Gershoni-Baruch, E Schubert, J Garber, D Stoppa-Lyonnet, E Olah, B Csokay, O Serova, F Lalloo,[...]. Am J Hum Genet 1998
132
13

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Timothy R Rebbeck, Nandita Mitra, Fei Wan, Olga M Sinilnikova, Sue Healey, Lesley McGuffog, Sylvie Mazoyer, Georgia Chenevix-Trench, Douglas F Easton, Antonis C Antoniou,[...]. JAMA 2015
297
13

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12

BRCA1 and BRCA2 mutations in a South American population.
Lilian Jara, Sandra Ampuero, Eudocia Santibáñez, Lorena Seccia, Juan Rodríguez, Mario Bustamante, Víctor Martínez, Alejandra Catenaccio, Guillermo Lay-Son, Rafael Blanco,[...]. Cancer Genet Cytogenet 2006
48
18

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome.
Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel Am Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt,[...]. Hered Cancer Clin Pract 2011
26
34

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
12

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
10

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
E C B da Costa, F R Vargas, A S Moreira, J J Lourenço, M Caleffi, P Ashton-Prolla, M A M Martins Moreira. Cancer Genet Cytogenet 2008
17
47

The contribution of BRCA1 and BRCA2 to ovarian cancer.
Susan J Ramus, Simon A Gayther. Mol Oncol 2009
128
10

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
Eva Machackova, Lenka Foretova, Mirka Lukesova, Petra Vasickova, Marie Navratilova, Ilse Coene, Hana Pavlu, Veronika Kosinova, Jitka Kuklova, Kathleen Claes. BMC Cancer 2008
56
14

BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson, Jeffrey N Weitzel, Steven A Narod. Gynecol Oncol 2012
48
16

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
Dirce Maria Carraro, Maria Aparecida Azevedo Koike Folgueira, Bianca Cristina Garcia Lisboa, Eloisa Helena Ribeiro Olivieri, Ana Cristina Vitorino Krepischi, Alex Fiorini de Carvalho, Louise Danielle de Carvalho Mota, Renato David Puga, Maria do Socorro Maciel, Rodrigo Augusto Depieri Michelli,[...]. PLoS One 2013
56
14

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Olah, Olufunmilayo I Olopade, Angela R Solano, Soo-Hwang Teo,[...]. Hum Mutat 2018
158
10

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
9

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
772
9

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Theodore Anagnostopoulos, Maroulio Pertesi, Irene Konstantopoulou, Sofia Armaou, Smaragda Kamakari, George Nasioulas, Athanassios Athanasiou, Alex Dobrovic, Mary-Anne Young, David Goldgar,[...]. Breast Cancer Res Treat 2008
31
22

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
9

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
N V Bogdanova, N N Antonenkova, Y I Rogov, J H Karstens, P Hillemanns, T Dörk. Clin Genet 2010
31
22



Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.
S V Tavtigian, A M Deffenbaugh, L Yin, T Judkins, T Scholl, P B Samollow, D de Silva, A Zharkikh, A Thomas. J Med Genet 2006
514
9

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
M Van Der Looij, C Szabo, I Besznyak, G Liszka, B Csokay, T Pulay, J Toth, P Devilee, M C King, E Olah. Int J Cancer 2000
80
9

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
559
9


Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
S L Neuhausen, S Mazoyer, L Friedman, M Stratton, K Offit, A Caligo, G Tomlinson, L Cannon-Albright, T Bishop, D Kelsell,[...]. Am J Hum Genet 1996
230
9

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
E Levy-Lahad, R Catane, S Eisenberg, B Kaufman, G Hornreich, E Lishinsky, M Shohat, B L Weber, U Beller, A Lahad,[...]. Am J Hum Genet 1997
231
9

The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.
R B Bar-Sade, A Kruglikova, B Modan, E Gak, G Hirsh-Yechezkel, L Theodor, I Novikov, R Gershoni-Baruch, S Risel, M Z Papa,[...]. Hum Mol Genet 1998
107
9

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
Anna P Sokolenko, Natalia V Mitiushkina, Konstantin G Buslov, Elena M Bit-Sava, Aglaya G Iyevleva, Elena V Chekmariova, Ekatherina Sh Kuligina, Yulia M Ulibina, Maxim E Rozanov, Evgeny N Suspitsin,[...]. Eur J Cancer 2006
58
12

High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.
Laima Tikhomirova, Olga Sinicka, Dagnija Smite, Janis Eglitis, Shirley V Hodgson, Aivars Stengrevics. Fam Cancer 2005
32
21

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
113
9

Haplotype of the C61G BRCA1 mutation in Polish and Jewish individuals.
Bella Kaufman, Yael Laitman, Jacek Gronwald, Jan Lubinski, Eitan Friedman. Genet Test Mol Biomarkers 2009
12
58

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
48
14

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
911
8

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
8

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Irene Konstantopoulou, Theodore Rampias, Angela Ladopoulou, George Koutsodontis, Sophia Armaou, Theodore Anagnostopoulos, George Nikolopoulos, Smaragda Kamakari, George Nounesis, Antonis Stylianakis,[...]. Breast Cancer Res Treat 2008
35
17


Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.
V F Esteves, L C S Thuler, L C Amêndola, R J Koifman, S Koifman, P P Frankel, R J S Vieira. Braz J Med Biol Res 2009
19
31


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.